iBio, Inc. (NYSEMKT:IBIO – Get Free Report)’s stock price shot up 1.7% during trading on Monday . The stock traded as high as $2.39 and last traded at $2.35. 40,857 shares traded hands during trading, a decline of 64% from the average session volume of 113,212 shares. The stock had previously closed at $2.31.
iBio Stock Up 1.7 %
The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.91 and a current ratio of 0.91. The company has a 50 day simple moving average of $2.63 and a 200 day simple moving average of $2.27.
About iBio
iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.
Featured Stories
- Five stocks we like better than iBio
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- 3 Best Fintech Stocks for a Portfolio Boost
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for iBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iBio and related companies with MarketBeat.com's FREE daily email newsletter.
